P109: Analysis of RASSF1A and DOK1 promoters methylation levels in hepatic tissues with and without hepatocellular carcinoma by pyrosequencing

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|75-76

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 75-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 11, 2015-11 ,pp. : 1110-1123

John Wiley & Sons Inc

Access to resources Recommend Favorite

RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin

By  

Oncology Research and Treatment, Vol. 35, Iss. 11, 2012-10 ,pp. : 673-682

Karger

Access to resources Recommend Favorite

P110: GSTM1, GSTT1, MDM2 and p53 polymorphisms and hepatitis C virus genetic variability in Brazilian patients with and without hepatocellular carcinoma

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 76-76

John Wiley & Sons Inc

Access to resources Recommend Favorite

P222: The prognostic value and biological effects of glycoprotein QSOX1 on recurrence and metastasis of hepatocellular carcinoma

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 131-132

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification by Differential Tissue Proteome Analysis of Talin-1 as a Novel Molecular Marker of Progression of Hepatocellular Carcinoma

By  

Oncology, Vol. 80, Iss. 5-6, 2011-08 ,pp. : 406-415

Karger

Access to resources Recommend Favorite